These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23040365)

  • 1. Catastrophic antiphospholipid syndrome (CAPS).
    Sciascia S; Lopez-Pedrera C; Roccatello D; Cuadrado MJ
    Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):535-41. PubMed ID: 23040365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAPS Registry.
    Cervera R
    Lupus; 2012 Jun; 21(7):755-7. PubMed ID: 22635223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of catastrophic antiphospholipid syndrome.
    Carmi O; Berla M; Shoenfeld Y; Levy Y
    Expert Rev Hematol; 2017 Apr; 10(4):365-374. PubMed ID: 28277850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catastrophic antiphospholipid syndrome.
    Cervera R; Asherton RA
    Pathophysiol Haemost Thromb; 2006; 35(1-2):181-6. PubMed ID: 16855368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome].
    Gu JY; Lu C; Shi H; Yang CD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catastrophic antiphospholipid syndrome: updated diagnostic algorithms.
    Erkan D; Espinosa G; Cervera R
    Autoimmun Rev; 2010 Dec; 10(2):74-9. PubMed ID: 20696282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the "CAPS Registry".
    Berman H; Rodríguez-Pintó I; Cervera R; Gregory S; de Meis E; Rodrigues CE; Aikawa NE; de Carvalho JF; Springer J; Niedzwiecki M; Espinosa G;
    Autoimmun Rev; 2014 Feb; 13(2):157-62. PubMed ID: 24145009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS).
    Agmon-Levin N; Rosário C; Katz BS; Zandman-Goddard G; Meroni P; Cervera R; Stojanovich L; Blank M; Pierangeli S; Praprotnik S; Meis Ed; Seguro LP; Ruffatti A; Pengo V; Tincani A; Doria A; Shoenfeld Y
    Lupus; 2013 Nov; 22(13):1327-35. PubMed ID: 24036580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome.
    Cervera R
    Curr Rheumatol Rep; 2010 Feb; 12(1):70-6. PubMed ID: 20425537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Catastrophic antiphospholipid syndrome: CAPS].
    Yamazaki M
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Dec; 28(6):357-64. PubMed ID: 16394638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab.
    Berman H; Rodríguez-Pintó I; Cervera R; Morel N; Costedoat-Chalumeau N; Erkan D; Shoenfeld Y; Espinosa G;
    Autoimmun Rev; 2013 Sep; 12(11):1085-90. PubMed ID: 23777822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse.
    Bucciarelli S; Erkan D; Espinosa G; Cervera R
    Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):80-4. PubMed ID: 19051065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catastrophic antiphospholipid syndrome (Ronald Asherson syndrome) and obstetric pathology.
    Makatsariya AD; Khizroeva J; Bitsadze VO
    J Perinat Med; 2018 May; 46(4):387-400. PubMed ID: 28829758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The catastrophic antiphospholipid syndrome in Serbia: diagnostic and management problems.
    Stojanovich L
    Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):98-103. PubMed ID: 19048415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Catastrophic antiphospholipid syndrome].
    Costedoat-Chalumeau N; Arnaud L; Saadoun D; Chastre J; Leroux G; Cacoub P; Amoura Z; Piette JC
    Rev Med Interne; 2012 Apr; 33(4):194-9. PubMed ID: 22341856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome.
    Asherson RA
    Immunobiology; 2005; 210(10):727-33. PubMed ID: 16325490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".
    Cervera R; Bucciarelli S; Plasín MA; Gómez-Puerta JA; Plaza J; Pons-Estel G; Shoenfeld Y; Ingelmo M; Espinos G;
    J Autoimmun; 2009; 32(3-4):240-5. PubMed ID: 19324520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid Syndrome and Catastrophic Antiphospholipid Syndrome: A Comprehensive Review of Pathogenesis, Clinical Features, and Management Strategies.
    Parepalli A; Sarode R; Kumar S; Nelakuditi M; Kumar MJ
    Cureus; 2024 Aug; 16(8):e66555. PubMed ID: 39252716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement.
    Rymarz A; Niemczyk S
    BMC Nephrol; 2018 Jun; 19(1):132. PubMed ID: 29884138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catastrophic antiphospholipid syndrome.
    Vora SK; Asherson RA; Erkan D
    J Intensive Care Med; 2006; 21(3):144-59. PubMed ID: 16672637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.